The Court of Appeals has rejected Sanofi Pasteur's appeal to reinstate the certificates of product registration (CPRs) for Dengvaxia, a dengue vaccine.
The Court of Appeals denied the petition of pharmaceutical company Sanofi Pasteur , Inc. (SPI), assailing the government’s decision to revoke its certificates of product registration ( CPR ) for the controversial Dengvaxia , a vaccine used for protection against dengue.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Court Of Appeals Sanofi Pasteur Petition Certificates Of Product Registration CPR Dengvaxia Vaccine Dengue